CANINE TUMOR TREATMENT METHOD, PHARMACEUTICAL FORMULATION APPLIED THERETO, AND METHOD OF CRYOGENICALLY PRESERVING CELLS USED THEREWITH

A treatment for tumorous canines and a method of preparing, cultivating, a nd cryogenically preserving the pharmaceutical formulation used in the treatmen t. Canine lymphocytes are activated and expanded in the presence of a combination of anti-canine CD3 antibodies and interleukin-2 (IL-2) (prefera...

Full description

Saved in:
Bibliographic Details
Main Authors BAMBA, KENZO, IINUMA, AKIKO, SEKINE, TERUAKI, ISHII, HIROSHI, OSUMI, KAZUOKI, KUROIWA, YASUYUKI
Format Patent
LanguageEnglish
French
Published 22.02.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A treatment for tumorous canines and a method of preparing, cultivating, a nd cryogenically preserving the pharmaceutical formulation used in the treatmen t. Canine lymphocytes are activated and expanded in the presence of a combination of anti-canine CD3 antibodies and interleukin-2 (IL-2) (preferab ly anti-canine CD3 antibodies and human interleukin-2 (human IL-2)) and administered to tumorous dogs. Following treatment, the canine tumors were observed to be in regression while no serious side effects were noted. Quality-of-life improvements were observed in the form of the animals' abili ty to walk increased distances and improved coat appearance.
Bibliography:Application Number: CA20062556473